COINCOIN
US • —
$146.19
P/E
55.55
PEG
—
FCF Yield
—
Rev Growth YoY
-5.8% YoY
Gross Margin
86.1%
Health Score
6/10
D/E Ratio
0.52
Confidence
MEDIUM
Business Snapshot
Coinbase Global operates a platform for trading and transacting cryptocurrencies, generating the majority of its revenue through transaction fees from retail and institutional users. The company operates in the highly volatile and regulatory-sensitive cryptocurrency exchange market, where it holds a position as a dominant player in the US. While its market capitalisation is not available, its operations are scaled across consumer and institutional segments. A defining characteristic is its deep dependence on cryptocurrency market cycles and trading volumes, making its financial performance highly sensitive to digital asset price movements and regulatory developments.
Financial Health
Gross margin stands at a robust 86.1%, indicating strong pricing power and low cost of revenue, though a prior-year comparison is not available for trend assessment. Net margin is 12.2% on a trailing twelve-month basis, suggesting moderate profitability after operating expenses...
Risk Assessment
- VALUATION — P/E ratio of 55.55x is at a significant premium to the sector average of 22x, leaving limited room for error.
- EARNINGS QUALITY — Only 2 of the last 4 quarters beat earnings estimates, reflecting mixed execution and guidance reliability.
- REVENUE DECELERATION — Revenue declined 5.8% year-over-year, reversing any prior growth trajectory and signalling a contractionary phase.
- TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed.
- 52-WEEK POSITION — The 52-week high and low are not available, preventing an assessment of the stock's current position within its annual range....
Gross margin stands at a robust 86.1%, indicating strong pricing power and low cost of revenue, though a prior-year comparison is not available for trend assessment. Net margin is 12.2% on a trailing twelve-month basis, suggesting moderate profitability after operating expenses. The balance sheet is healthy, with a debt-to-equity ratio of 0.52x and a current ratio of 2.34x, indicating conservative leverage and ample short-term liquidity. Free cash flow data is not available, preventing an assessment of cash generation efficiency. Overall, the company has a sound balance sheet and wide gross margins, but the absence of free cash flow data limits full financial health evaluation.
- VALUATION — P/E ratio of 55.55x is at a significant premium to the sector average of 22x, leaving limited room for error. - EARNINGS QUALITY — Only 2 of the last 4 quarters beat earnings estimates, reflecting mixed execution and guidance reliability. - REVENUE DECELERATION — Revenue declined 5.8% year-over-year, reversing any prior growth trajectory and signalling a contractionary phase. - TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed. - 52-WEEK POSITION — The 52-week high and low are not available, preventing an assessment of the stock's current position within its annual range.
Unlock the full AI report
Full 8-section analysis includes:
Metric deep-dives